These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16925575)

  • 1. The evolution towards ambulatory and day-case management of febrile neutropenia.
    Chisholm JC; Dommett R
    Br J Haematol; 2006 Oct; 135(1):3-16. PubMed ID: 16925575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient therapy for febrile neutropenia.
    Innes H; Marshall E
    Curr Opin Oncol; 2007 Jul; 19(4):294-8. PubMed ID: 17545790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cherif H; Johansson E; Björkholm M; Kalin M
    Haematologica; 2006 Feb; 91(2):215-22. PubMed ID: 16461306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
    Rubenstein EB; Rolston KV; Kim YJ
    N Engl J Med; 2000 Jan; 342(1):56; author reply 56-8. PubMed ID: 10627211
    [No Abstract]   [Full Text] [Related]  

  • 5. [Febrile neutropenia in the child with cancer. Current concepts about risk assessment and selective management].
    Santolaya ME
    Rev Med Chil; 2001 Dec; 129(12):1449-54. PubMed ID: 12080883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
    Mullen CA
    Pediatr Infect Dis J; 2003 Dec; 22(12):1138-42. PubMed ID: 14688588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
    Sung L; Feldman BM; Schwamborn G; Paczesny D; Cochrane A; Greenberg ML; Maloney AM; Hendershot EI; Naqvi A; Barrera M; Llewellyn-Thomas HA
    J Clin Oncol; 2004 Oct; 22(19):3922-9. PubMed ID: 15459214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.
    Rolston KV; Manzullo EF; Elting LS; Frisbee-Hume SE; McMahon L; Theriault RL; Patel S; Benjamin RS
    Cancer; 2006 Jun; 106(11):2489-94. PubMed ID: 16628654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
    Sezer O
    N Engl J Med; 2000 Jan; 342(1):56; author reply 56-8. PubMed ID: 10627212
    [No Abstract]   [Full Text] [Related]  

  • 11. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
    Hodgson-Viden H; Grundy PE; Robinson JL
    BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Empirical antibiotic therapy for febrile neutropenia].
    Kridel R; Van Delden C; Calandra T; Marchetti O
    Rev Med Suisse; 2008 Apr; 4(152):914, 916-9. PubMed ID: 18578432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.
    Heuser M; Ganser A; Bokemeyer C; ; ;
    Semin Hematol; 2007 Jul; 44(3):148-56. PubMed ID: 17631179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of febrile neutropenia in pediatric oncology patients: a Canadian survey.
    Boragina M; Patel H; Reiter S; Dougherty G
    Pediatr Blood Cancer; 2007 May; 48(5):521-6. PubMed ID: 16724314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment and treatment of low-risk patients with febrile neutropenia.
    Kern WV
    Clin Infect Dis; 2006 Feb; 42(4):533-40. PubMed ID: 16421798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
    J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment in fever and neutropenia in children with cancer: What did we learn?
    te Poele EM; Tissing WJ; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):45-55. PubMed ID: 19195908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric therapy for febrile neutropenia: what are the choices?
    Aoun M
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):507-15. PubMed ID: 17547514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C; Russo E; Carmosino I; Breccia M; Dragoni F; Latagliata R; Mecarocci S; Morano SG; Stefanizzi C; Alimena G
    Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.